title: Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.
authors.forename: T
authors.initials: T
authors.lastname: Valentin
authors.forename: P
authors.initials: P
authors.lastname: Neumeister
authors.forename: M
authors.initials: M
authors.lastname: Pichler
authors.forename: A
authors.initials: A
authors.lastname: Rohn
authors.forename: C
authors.initials: C
authors.lastname: Koidl
authors.forename: D
authors.initials: D
authors.lastname: Haas
authors.forename: B
authors.initials: B
authors.lastname: Heiling
authors.forename: M
authors.initials: M
authors.lastname: Asslaber
authors.forename: I
authors.initials: I
authors.lastname: Zollner-Schwetz
authors.forename: M
authors.initials: M
authors.lastname: Hoenigl
authors.forename: H J F
authors.initials: HJ
authors.lastname: Salzer
authors.forename: R
authors.initials: R
authors.lastname: Krause
authors.forename: W
authors.initials: W
authors.lastname: Buzina
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D032641:Eurotiales; D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000150:complications* / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008172:Lung Diseases, Fungal / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
chemical_list: D000911:Antibodies, Monoclonal; D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D000069285:Infliximab; D065819:Voriconazole